This study aims to develop and validate a contrast-enhanced CT-based deep-learning model for automatic and accurate preoperative discrimination between T1-T2 and T3 renal cell carcinoma. By quantifying the model's diagnostic performance on an independent test set-using AUC, sensitivity, specificity, positive/negative predictive values, and decision-curve analysis-we will establish a decision-support tool that can be seamlessly integrated into clinical PACS, thereby reducing staging errors, refining surgical planning, and improving patient outcomes.
Study Type
OBSERVATIONAL
Enrollment
1,000
this study is retrospective based on the CT images, which dose include any intervention.
Peking University First Hospital, Beijing,
Beijing, China
RECRUITINGdiagnostic performance
Time frame: from 2024 to 2027
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.